Applied Clinical Trials Named Jesse H. Neal National Business Journalism Award Finalist
Applied Clinical Trials has been honored by American Business Media as a finalist in the 57th Annual Jesse H. Neal National Business Journalism Awards competition for editorial excellence. Applied Clinical Trials is one of 123 finalists selected by a distinguished board of judges for its
The judging panel, chaired by Abe Peck of Northwestern University’s Medill School of Journalism, selected the
Paying tribute to the Neal Award finalists, American Business Media President & CEO Clark Pettit said, “We at ABM are so proud to honor these journalists and editors. Their expertise, ability to push progress across existing and new channels, and successful track records of informing the industry on important issues place them at the forefront of their fields.”
Established in 1955, the Jesse H. Neal National Business Journalism Awards recognize and reward editorial excellence in business media. The awards are named after American Business Media’s first managing director who remained active in promoting the industry throughout his life. The Neal Awards are presented annually to those editors who have submitted entries exhibiting journalistic enterprise, service to the field and editorial craftsmanship.
Entries are divided into three classifications according to the publication’s advertising and circulation revenue, with 12 editorial categories within each size classification and seven categories that do not require revenue figures. Material must have been published between December 1, 2009, and November 30, 2010.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025